Anti-Inflammatory and Neuroactive Properties of Selected Fruit Extracts

다국어 초록 (Multilingual Abstract)

Epidemiological evidence supports inverse associations between fruit and vegetable intake and incidence of cardiovascular disease and neurodegeneration. Dietary botanicals with salient health benefits include berries and leafy vegetables. Molecular pharmacology research has ascribed these benefits primarily to phenolic constituents and antioxidant activity. The current investigation sought to eluicidate pharmacologic activity of two novel preparations of berry and spinach extracts in vitro. Blueberry and cranberry exhibited the greatest antioxidant activity. In a dose-dependent manner, a proprietary mixture of cranberry and blueberry extracts inhibited inhibitor of κB kinase β, a central node in inflammatory signal transduction. A proprietary mixture of blueberry, strawberry, and spinach extracts inhibited prolyl endopeptidase, a regulator of central neuropeptide stability and an emerging therapeutic target in neurology and psychiatry. These results indicate specific molecular targets of blended dietary plants with potential relevance to inflammation and neurological health.

참고문헌 (Reference)

1 Seeram NP, "Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines" 52 : 2512-2517, 2004

2 Lawrence T, "The nuclear factor NF-kappaB pathway in inflammation" 1 : a001651-, 2009

3 Tarragó T, "The natural product berberine is a human prolyl oligopeptidase inhibitor" 2 : 354-359, 2007

4 Spencer JP, "The impact of fruit flavonoids on memory and cognition" 104 : S40-S47, 2010

5 Park DH, "Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances" ELSEVIER SCIENCE BV 81 : 644-648, 201009

6 Avila CM, "Structural insights into IKKb inhibition by natural products staurosporine and quercetin" 19 : 6907-6910, 2009

7 Finney JD, "Statistical Methods in Biological Assay" Charles Griffin 58-65, 1978

8 Van der Heiden K, "Role of nuclear factor kappaB in cardiovascular health and disease" 118 : 593-605, 2010

9 Joseph JA, "Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation" 19 : 8114-8121, 1999

10 Männisto PT, "Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders" 20 : 293-305, 2007

11 Kobayashi W, "Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F. Vill" 25 : 1049-1052, 2002

12 Liu RH, "Potential synergy of phytochemicals in cancer prevention: mechanism of action" 134 : 3479S-3485S, 2004

13 Hannum SM, "Potential impact of strawberries on human health: a review of the science" 44 : 1-17, 2004

14 Son PS, "Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-kappa B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK beta as a potential target" OXFORD UNIV PRESS 31 (31): 1442-1449, 201008

15 Kim J, "Naturally occurring phytochemicals for the prevention of Alzheimer’s disease" 112 : 1415-1430, 2010

16 Cao G, "Measurement of oxygen radical absorbance capacity in biological samples" 299 : 50-62, 1999

17 Stoner GD, "Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries" 29 : 1665-1674, 2008

18 Gilmore TD, "Inhibitors of NFkB signaling: 785 and counting" 25 : 6887-6899, 2006

19 Papandreou MA, "Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity" 198 : 352-358, 2009

20 Lomnitski L, "Composition, efficacy, and safety of spinach extracts" 46 : 222-231, 2003

21 Côté J, "Bioactive compounds in cranberries and their biological properties" 50 : 666-679, 2010

22 Zafra-Stone S, "Berry anthocyanins as novel antioxidants in human health and disease prevention" 51 : 675-683, 2007

23 Paredes-López O, "Berries: improving human health and healthy aging, and promoting quality life—a review" 65 : 299-308, 2010

24 Basu A, "Berries: emerging impact on cardiovascular health" 68 : 168-177, 2010

25 Tarragó T, "Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor" 16 : 7516-7524, 2008

26 Momeni N, "Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders" 5 : 27-, 2005

27 Toide K, "A novel prolyl endopeptidase inhibitor, JTP-4819—its behavioral and neurochemical properties for the treatment of Alzheimer’s disease" 9 : 17-29, 1998